Keros Therapeutics shares owned by Handelsbanken Fonder AB
Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Handelsbanken Fonder AB
from 13F filings
Historical chart of Handelsbanken Fonder AB investment in Keros Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Keros Therapeutics held by Handelsbanken Fonder AB consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Keros Therapeutics by Handelsbanken Fonder AB
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $563k | 9.7k | 58.04 |
| 2024-06-30 | $366k | 8.0k | 45.75 |
| 2024-03-31 | $444k | 6.7k | 66.27 |
| 2023-12-31 | $266k | 6.7k | 39.70 |
| 2023-09-30 | $214k | 6.7k | 31.94 |
| 2023-06-30 | $269k | 6.7k | 40.15 |
| 2023-03-31 | $312k | 7.3k | 42.74 |
| 2022-12-31 | $351k | 7.3k | 48.08 |
| 2022-03-31 | $402k | 7.4k | 54.32 |
| 2021-12-31 | $433k | 7.4k | 58.51 |